ReWalk Robotics (NASDAQ:RWLK – Get Free Report) and Anzu Special Acquisition Corp I (NASDAQ:ANZU – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, valuation and earnings.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for ReWalk Robotics and Anzu Special Acquisition Corp I, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ReWalk Robotics | 0 | 0 | 1 | 0 | 3.00 |
| Anzu Special Acquisition Corp I | 0 | 0 | 0 | 0 | N/A |
ReWalk Robotics currently has a consensus target price of $3.00, indicating a potential upside of 379.23%. Given ReWalk Robotics’ higher probable upside, research analysts clearly believe ReWalk Robotics is more favorable than Anzu Special Acquisition Corp I.
Volatility and Risk
Profitability
This table compares ReWalk Robotics and Anzu Special Acquisition Corp I’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| ReWalk Robotics | -350.43% | -27.83% | -25.57% |
| Anzu Special Acquisition Corp I | N/A | -17.33% | 1.37% |
Earnings & Valuation
This table compares ReWalk Robotics and Anzu Special Acquisition Corp I’s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| ReWalk Robotics | $5.63 million | 6.66 | -$19.57 million | ($0.33) | -1.90 |
| Anzu Special Acquisition Corp I | N/A | N/A | $19.23 million | N/A | N/A |
Anzu Special Acquisition Corp I has lower revenue, but higher earnings than ReWalk Robotics.
Institutional and Insider Ownership
3.6% of ReWalk Robotics shares are owned by institutional investors. Comparatively, 27.3% of Anzu Special Acquisition Corp I shares are owned by institutional investors. 2.1% of ReWalk Robotics shares are owned by insiders. Comparatively, 0.7% of Anzu Special Acquisition Corp I shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
About ReWalk Robotics
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.
About Anzu Special Acquisition Corp I
Anzu Special Acquisition Corp I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of industrial applications. Anzu Special Acquisition Corp I was incorporated in 2020 and is based in Tampa, Florida. Anzu Special Acquisition Corp I operates as a subsidiary of Anzu SPAC GP I LLC.
Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.
